Tag: cancer
-
Feasibility, Safety Shown for Personal Tumor Vaccine
A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor.
-
NIH Funds Nanotech Tools for Cancer, Blood Clots
A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots.
-
Second Trial Approved for Cancer Pain Drug
The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer.
-
Cancer Drug Produced in Small Continuous-Flow Batches
A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing.
-
Supreme Court Cuts Biosimilar Waiting Time
The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products.
-
Cancer Center to Test Focused Radiation Therapy
MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy.
-
Symptom Alerts Linked to Longer Cancer Survival
A clinical trial shows cancer patients using an online system to report their symptoms have somewhat longer survival times than patients not using this service.
-
Engineered Immune Cells to be Explored for Solid Tumors
A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers.
-
$10M Cancer Immunotherapy Research Fund Launched
A foundation is sponsoring research grants totaling $10 million for computational solutions to key questions facing cancer immunotherapy.
-
Trial to Test Spherical Nanotech Brain Cancer Drug
An early-stage clinical trial will soon begin testing spherically-shaped nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.